Last update 23 Jan 2025

KCNQ (Kv7) x GABAA receptor

Basic Info

Related Targets
KCNQ (Kv7)GABAA receptor

Related

1
Drugs associated with KCNQ (Kv7) x GABAA receptor
Ezogabine
Target
GABAA receptor x KCNQ (Kv7)
Mechanism
GABAA receptor agonists [+1]
Active Org.-
Originator Org.
GSK PlcGSK Plc
Active Indication-
Inactive Indication
Amyotrophic Lateral Sclerosis [+10]
Drug Highest PhaseWithdrawn
First Approval Ctry. / Loc.
EU [+3]
First Approval Date27 Mar 2011
35
Clinical Trials associated with KCNQ (Kv7) x GABAA receptor
NCT04912856
/ TerminatedPhase 3
An Open-Label Extension of the Study XEN496 in Children With KCNQ2 Developmental and Epileptic Encephalopathy
NCT04639310
/ TerminatedPhase 3
A Phase 3 Study of Adjunctive XEN496 in Pediatric Subjects With KCNQ2 Developmental and Epileptic Encephalopathy
CTR20182420
/ CompletedPhase 1
瑞替加滨片单次给药在健康受试者体内的药代动力学预试验
[Translation] Preliminary study on the pharmacokinetics of single-dose retigabine tablets in healthy volunteers
100 Clinical Results associated with KCNQ (Kv7) x GABAA receptor
Login to view more data
100 Translational Medicine associated with KCNQ (Kv7) x GABAA receptor
Login to view more data
0 Patents (Medical) associated with KCNQ (Kv7) x GABAA receptor
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free